Prostacyclin in pregnancy.
D015121:6-Ketoprostaglandin F1 alpha / Q000096:biosynthesis / Q000097:blood; D000222:Adaptation, Physiological; D000818:Animals; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors / Q000502:physiology; D011464:Epoprostenol / Q000096:biosynthesis / Q000502:physiology*; D005260:Female; D005313:Fetal Death / Q000209:etiology; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007093:Imidazoles / Q000627:therapeutic use; D016682:Lupus Coagulation Inhibitor; D011225:Pre-Eclampsia / Q000209:etiology; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy / Q000209:etiology; D051381:Rats; D013927:Thrombosis / Q000209:etiology; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors; D014811:Vitamin E Deficiency / Q000150:complications
D001779:Blood Coagulation Factors; D007093:Imidazoles; D016682:Lupus Coagulation Inhibitor; C029166:dazoxiben; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol; D013930:Thromboxane-A Synthase